Company: CERO
Filing Date: 2025-02-06
Form Type: 8-K
Source: 0001213900-25-010731
Chunk: 2

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-06
Form: 8-K
Item: Item 8.01
Chunk 2
---
Item
8.01 Other Events.

The
Company issued a press release announcing the pricing of the Offering on February 5, 2025. A copy of the press release is furnished herewith
as Exhibit 99.1.

Item
9.01. Financial Statements and Exhibits.

(d)
Exhibits.

  Exhibit      Description                                                                                                          
   Number                                                                                                                           
      1.1      Placement Agency Agreement, dated February 5, 2025 by and between the Company and A. G. P./Alliance Global Partners  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
      4.1      Form of Common Warrant                                                                                               
     10.1      Form of Securities Purchase Agreement by and between the Company and the investors named therein.                    
     99.1      Press Release (Pricing) dated February 5, 2025                                                                       
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                          

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                              CERo Therapeutics                               
  Date: February 6, 2025      By:                    /s/ Chris Ehrlich        
                                                     Chris Ehrlich            
                                                     Chief Executive Officer